Company Overview and News
May 22, 2018: Markets opened higher again Tuesday but it’s been a bumpy day ever since, especially for the blue chips. Trading has been mixed all day with the energy sector the day’s biggest loser while financials and utilities have performed best. The FOMC releases the tea leaves, uh, minutes, of its latest meeting tomorrow. A slightly weakening dollar and still-high 10-year yields pretty much offset each other.
Summer vacation is just around the corner. For most of us, that represents some potential rest. But savvy investors are looking for summer vacation stocks.
A good 2018 first quarter but the stock has pulled back due to putting cash into the pension fund and missing analyst EPS consensus.
The Boeing Company (BA - Free Report) recently won a task order to support F/A-18 A-F and EA-18G aircrafts for the U.S. Navy and the government of Australia. Work related to the deal is scheduled to be over by July 2022.
As shares of General Electric Company (NYSE:GE) have plunged, the calls for a breakup have grown louder. Bulls see the true value of GE stock as clouded by issues at GE Capital and weakness in divisions such as Lighting and Transportation. With two still-growing businesses — Aviation and Healthcare — plus a 62.5% stake in Baker Hughes a GE Co (NYSE:BHGE), optimists argue there has to be some value in General Electric stock, particularly after a 50%-plus decline from 2016 highs.
Wall Street’s biggest dampener for the last few months will be offset now as the United States and China put trade war on hold. The world’s largest economies dropped their tariff threats and set up a framework to address potential trade imbalances in the future. China has promised to purchase more U.S. goods and services, including energy and agricultural products that would support growth and employment in the United States.
The United States and China have agreed to “substantially” lessen trade deficit following two days of negotiations. China promised to “significantly” purchase U.S. goods and services that soothed investors’ nerves to a fair extent.
U.S. equities were on a roll on Monday that looks set to continue Tuesday, with the Dow Jones Industrial Average crossing the 25,000 threshold for the first time since March.
It now appears that some trade wars are not really trade wars at all, but starting bargaining positions.
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, May 21.
SYDNEY: Australian investigators on Tuesday (May 22) defended their findings that missing Malaysia Airlines flight MH370 was out of control when it plunged into the ocean, despite renewed theories that a rogue pilot ditched the plane.
Underappreciated transformation story driven by a multi-year restructuring focused on cost-savings and a strategic shift to higher value products.
China, in the early stages of a trade war with the U.S., said is would lower some tariffs. According to CNBC:
BEIJING (AP) — Asian markets were mostly lower Tuesday after Wall Street gained as Italy moved toward forming a euroskeptic-led government.
May 22 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET